Home » Public Sector » IOL Chemicals and Pharmaceuticals reports strong Q4FY23 results

Public Sector

IOL Chemicals and Pharmaceuticals reports strong Q4FY23 results

IOL Chemicals

IOL Chemicals & Pharmaceuticals reports strong results

IOL Chemicals and Pharmaceuticals Ltd, a prominent maker of pharmaceutical APIs and specialty chemicals, has released its fourth-quarter and fiscal-year 2023 financial results.

IOL Chemicals

Financial Highlights for the Fourth Quarter of Fiscal Year 23

Total income for Q4 FY23 was Rs. 596 crore, up from Rs. 530 crore in Q3 and Rs.579 crore year on year.

EBITDA for Q4 FY23 was Rs. 104 crore, up from Rs. 50 crore in Q3 and Rs. 50 crore year on year.

Financial Highlights for Fiscal Year 23

Total income for FY23 was Rs. 2,243 crore, compared to Rs. 2,216 crore in FY22.

EBITDA for FY23 was Rs. 252 crore, compared to Rs. 288 crore in FY22.

Mr Vikas Gupta, Joint Managing Director, commented on the performance, saying, “The last quarter of the fiscal year has come out strong for us as we stabilized our operations in the pharma and specialty chemicals segments with a focus on cost rationalization and margin improvement.”

We feel we are on a favorable rising trajectory because of considerable operational, technical, and commercial efficiency, enhanced market combination, and the expectation of long-term demand as an alternative to China.